Chemotherapy and G-CSF for Mobilization
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Vinorelbine
Related studies linked through entity extraction aliases.
The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial
- Status
- UNKNOWN
- Phase
- PHASE3
Vinorelbine for Recurrent ACLC
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy
- Status
- TERMINATED
- Phase
- N/A
Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)
- Status
- COMPLETED
- Phase
- PHASE2
MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE4
Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PemVin vs Vin in Previously Treated Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE3
Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
MEtronomic TrEatment Option in Advanced bReast cAncer
- Status
- COMPLETED
- Phase
- PHASE2